Total reported value
$315.1M
Reporting period: 2026-03-31 · Number of holdings: 114
Seven Fleet Capital Management LP disclosed 114 holdings in its latest 13F filing for the period ending 2026-03-31, with total reported value of $315.1M and a quarterly turnover rate of 147.1%.
Browse other institutions with $100M to $1B AUMBrowse other institutions starting with "S"
Trim CGON
-95.0% -$57.8M
Trim COGT
-30.2% -$1.9M
Trim SLNOEUR
-11.0% -$2.1M
Add TNGX
+133.3% $8.6M
Add AGIO
+560.2% $6.2M
Add PCVX
+327.6% $5.1M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ✓ | Cg Oncology INC | Stock-Other | 30.92% | +30.92% | NEW | |
| 2 | TNGX | Tango Therapeutics INC | Stock-Other | 3.33% | +2.04% | +133.31% | |
| 3 | RVMD | Revolution Medicines INC | Stock-Healthcare | 2.49% | -1.06% | +22.78% | |
| 4 | TYRA | Tyra Biosciences INC | Stock-Other | 2.38% | +0.96% | +145.96% | |
| 5 | LQDA | Liquidia CORP | Stock-Other | 2.25% | +0.12% | +105.85% | |
| 6 | AGIO | Agios Pharmaceuticals INC | Stock-Other | 2.25% | +1.67% | +560.24% | |
| 7 | IPSC | Century Therapeutics INC | Stock-Other | 2.11% | +2.11% | NEW | |
| 8 | ELVN | Enliven Therapeutics INC | Stock-Other | 2.04% | +1.00% | +64.11% | |
| 9 | PCVX | Vaxcyte INC | Stock-Other | 2.00% | +1.21% | +327.56% | |
| 10 | ✓ | Tango Therapeutics INC | Stock-Other | 2.00% | +2.00% | NEW | |
| 11 | COGT | Cogent Biosciences INC | Stock-Other | 1.82% | -3.33% | -30.22% | |
| 12 | ✓ | Avalo Therapeutics INC | Stock-Other | 1.71% | +1.71% | NEW | |
| 13 | ✓ | Minerva Neurosciences INC | Stock-Other | 1.70% | +1.70% | NEW | |
| 14 | CGON | Cg Oncology INC | Stock-Other | 1.63% | -40.94% | -95.00% | |
| 15 | PHVS | Pharvaris N.V. | Stock-Other | 1.55% | +0.51% | +212.12% | |
| 16 | ABVX | Abivax Sa-adr | Stock-Other | 1.52% | +0.29% | +218.93% | |
| 17 | DNTH | Dianthus Therapeutics INC | Stock-Other | 1.45% | +1.04% | +270.34% | |
| 18 | ✓ | Pharvaris N V | Stock-Other | 1.29% | +1.29% | NEW | |
| 19 | CYTK | Cytokinetics INC | Stock-Healthcare | 1.28% | +0.84% | +492.83% | |
| 20 | SLNOEUR | Soleno Therapeutics INC | Stock-Other | 1.23% | -2.85% | -11.00% | |
| 21 | ✓ | Enliven Therapeutics INC | Stock-Other | 1.19% | +1.18% | NEW | |
| 22 | ERAS | Erasca INC | Stock-Other | 1.14% | +1.14% | NEW | |
| 23 | ROIV | Roivant Sciences Ltd. | Stock-Healthcare | 1.13% | +1.13% | NEW | |
| 24 | ✓ | Cytomx Therapeutics INC. | Stock-Other | 1.07% | +1.06% | NEW | |
| 25 | AVTX | Avalo Therapeutics INC | Stock-Other | 1.01% | +0.23% | +237.56% | |
| 26 | EPRX | Eupraxia Pharmaceuticals INC | Stock-Other | 1.00% | +1.00% | NEW | |
| 27 | IDYA | Ideaya Biosciences INC | Stock-Other | 0.91% | +0.91% | NEW | |
| 28 | TSHA | Taysha Gene Therapies INC | Stock-Other | 0.89% | +0.27% | +274.18% | |
| 29 | ASND | Ascendis Pharma A/S | Stock-Other | 0.88% | +0.06% | +114.80% | |
| 30 | CMPX | Compass Therapeutics INC | Stock-Other | 0.87% | — | -9.10% | |
| 31 | DMRA | Damora Therapeutics INC | Stock-Other | 0.83% | +0.83% | NEW | |
| 32 | 4XC1 | Kalvista Pharmaceuticals INC | Stock-Other | 0.82% | +0.29% | +165.40% | |
| 33 | RLAY | Relay Therapeutics INC | Stock-Other | 0.81% | +0.39% | +253.07% | |
| 34 | AXSM | Axsome Therapeutics INC | Stock-Healthcare | 0.75% | — | +8.49% | |
| 35 | ✓ | Compass Therapeutics INC | Stock-Other | 0.71% | +0.71% | NEW | |
| 36 | ✓ | Dianthus Therapeutics INC | Stock-Other | 0.71% | +0.71% | NEW | |
| 37 | ✓ | Eupraxia Pharmaceuticals INC | Stock-Other | 0.63% | +0.63% | NEW | |
| 38 | DFTX | Definium Therapeutics INC | Stock-Other | 0.60% | +0.60% | NEW | |
| 39 | MLYS | Mineralys Therapeutics INC | Stock-Other | 0.60% | — | +65.55% | |
| 40 | ✓ | Soleno Therapeutics INC | Stock-Other | 0.57% | +0.57% | NEW | |
| 41 | MDGL | Madrigal Pharmaceuticals INC | Stock-Healthcare | 0.56% | — | +82.42% | |
| 42 | CTMX | Cytomx Therapeutics INC | Stock-Other | 0.55% | +0.41% | +659.54% | |
| 43 | LONA | Leonabio INC | Stock-Other | 0.54% | — | +28.70% | |
| 44 | SVRA | Savara INC | Stock-Other | 0.51% | +0.25% | +371.13% | |
| 45 | CATX | Perspective Therapeutics INC | Stock-Other | 0.50% | +0.50% | NEW | |
| 46 | ASMB | Assembly Biosciences INC | Stock-Other | 0.49% | — | -23.88% | |
| 47 | ✓ | Sab Biotherapeutics INC | Stock-Other | 0.49% | +0.49% | NEW | |
| 48 | NERV | Minerva Neurosciences INC | Stock-Other | 0.48% | +0.48% | NEW | |
| 49 | ZLAB | Zai Lab Ltd-adr | Stock-Other | 0.46% | +0.46% | NEW | |
| 50 | TARS | Tarsus Pharmaceuticals INC | Stock-Other | 0.44% | — | +340.00% |
Performance for Q3 2026
-1.3%
Performance Last 4 Quarters
+8.8%
Based on 3 months of available history
Based on 43% of reported portfolio value with available pricing
Seven Fleet Capital Management LP's most significant position changes for 2026-03-31: New buy: Cg Oncology INC; New buy: Century Therapeutics INC (IPSC); New buy: Tango Therapeutics INC; New buy: Avalo Therapeutics INC; New buy: Minerva Neurosciences INC.
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | TNGX | Tango Therapeutics INC | +2% | +133.31% | Add |
| 2 | AGIO | Agios Pharmaceuticals INC | +1.7% | +560.24% | Add |
| 3 | PCVX | Vaxcyte INC | +1.2% | +327.56% | Add |
| 4 | DNTH | Dianthus Therapeutics INC | +1% | +270.34% | Add |
| 5 | ELVN | Enliven Therapeutics INC | +1% | +64.11% | Add |
| 6 | TYRA | Tyra Biosciences INC | +1% | +145.96% | Add |
| 7 | CYTK | Cytokinetics INC | +0.8% | +492.83% | Add |
| 8 | PHVS | Pharvaris N.V. | +0.5% | +212.12% | Add |
| 9 | CTMX | Cytomx Therapeutics INC | +0.4% | +659.54% | Add |
| 10 | RLAY | Relay Therapeutics INC | +0.4% | +253.07% | Add |
| 11 | ABVX | Abivax Sa-adr | +0.3% | +218.93% | Add |
| 12 | 4XC1 | Kalvista Pharmaceuticals INC | +0.3% | +165.40% | Add |
| 13 | TSHA | Taysha Gene Therapies INC | +0.3% | +274.18% | Add |
| 14 | SVRA | Savara INC | +0.3% | +371.13% | Add |
| 15 | AVTX | Avalo Therapeutics INC | +0.2% | +237.56% | Add |
| 16 | LQDA | Liquidia CORP | +0.1% | +105.85% | Add |
| 17 | ASND | Ascendis Pharma A/S | +0.1% | +114.80% | Add |
| 18 | RVMD | Revolution Medicines INC | -1.1% | +22.78% | Add |
| 19 | SLNOEUR | Soleno Therapeutics INC | -2.9% | -11.00% | Trim |
| 20 | COGT | Cogent Biosciences INC | -3.3% | -30.22% | Trim |
| 21 | CGON | Cg Oncology INC | -40.9% | -95.00% | Trim |
| 22 | ✓ | Cg Oncology INC | — | NEW | New buy |
| 23 | IPSC | Century Therapeutics INC | — | NEW | New buy |
| 24 | ✓ | Tango Therapeutics INC | — | NEW | New buy |
| 25 | ✓ | Avalo Therapeutics INC | — | NEW | New buy |
| 26 | ✓ | Minerva Neurosciences INC | — | NEW | New buy |
| 27 | 430 | Terns Pharmaceuticals INC | — | EXIT | Sold out |
| 28 | ✓ | Pharvaris N V | — | NEW | New buy |
| 29 | ✓ | Enliven Therapeutics INC | — | NEW | New buy |
| 30 | ERAS | Erasca INC | — | NEW | New buy |
| 31 | ROIV | Roivant Sciences Ltd. | — | NEW | New buy |
| 32 | ✓ | Cytomx Therapeutics INC. | — | NEW | New buy |
| 33 | EPRX | Eupraxia Pharmaceuticals INC | — | NEW | New buy |
| 34 | EXEL | Exelixis INC | — | EXIT | Sold out |
| 35 | IDYA | Ideaya Biosciences INC | — | NEW | New buy |
| 36 | DMRA | Damora Therapeutics INC | — | NEW | New buy |
| 37 | ✓ | Compass Therapeutics INC | — | NEW | New buy |
| 38 | ✓ | Dianthus Therapeutics INC | — | NEW | New buy |
| 39 | ✓ | Eupraxia Pharmaceuticals INC | — | NEW | New buy |
| 40 | DFTX | Definium Therapeutics INC | — | NEW | New buy |
| 41 | ✓ | Soleno Therapeutics INC | — | NEW | New buy |
| 42 | CATX | Perspective Therapeutics INC | — | NEW | New buy |
| 43 | ✓ | Sab Biotherapeutics INC | — | NEW | New buy |
| 44 | NERV | Minerva Neurosciences INC | — | NEW | New buy |
| 45 | BLTE | Belite Bio INC - Adr | — | EXIT | Sold out |
| 46 | ZLAB | Zai Lab Ltd-adr | — | NEW | New buy |
| 47 | DYN | Dyne Therapeutics INC | — | EXIT | Sold out |
| 48 | CRVS | Corvus Pharmaceuticals INC | — | NEW | New buy |
| 49 | AM6 | Amicus Therapeutics INC | — | EXIT | Sold out |
| 50 | ✓ | Vaxcyte INC | — | NEW | New buy |
Institutions with a similar AUM
CIK 0002038170
Total reported value
$315.1M
56 stks
2025-12-31
Stale — no recent filing
AUM within 0.0% of this institution
CIK 0001904664
Total reported value
$315.1M
48 stks
2026-03-31
AUM within 0.0% of this institution
CIK 0002033920
Total reported value
$315.1M
69 stks
2026-03-31
AUM within 0.0% of this institution
Institutions with overlapping top holdings
CIK 0001595430
Total reported value
$1.4B
17 stks
2026-03-31
3 of the top 5 holdings overlap, including Revolution Medicines INC
CIK 0001678378
Total reported value
$468.9M
6 stks
2026-03-31
2 of the top 5 holdings overlap, including Revolution Medicines INC
CIK 0001727492
Total reported value
$1.5B
28 stks
2026-03-31
2 of the top 5 holdings overlap, including Liquidia CORP